LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease. Alzforum, 18 Feb 2022 Chang EE, Ho PW, Liu HF, Pang SY, Leung CT, Malki Y, Choi ZY, Ramsden DB, Ho SL.